Interpace Diagnostics (NASDAQ:IDXG) shares ticked higher today, after the pathology services and molecular diagnostic tests firm announced that Blue Cross Blue Shield of …
Maxim analyst Jason McCarthy is out today with a research note on shares of Interpace Diagnostics (NASDAQ:IDXG), after the company released first-quarter results, posting $4.8 …
Analyst Jason Kolbert of Maxim believes that Interpace Diagnostics Group Inc (NASDAQ:IDXG) has quite the upper hand over the leading market ruler Veracyte …
Shares of Interpace Diagnostics Group Inc (NASDAQ:IDXG) are marching higher this morning after the diagnostic company announced that it has signed a new national contract …
Interpace Diagnostics Group Inc (NASDAQ:IDXG) investors have a smile on their faces Monday morning, after the company announced that Premera Blue Cross, the largest …
Shareholders of Interpace Diagnostics Group Inc (NASDAQ:IDXG) are having a rough morning, after the diagnostic company announced the pricing of an underwritten public …
Interpace Diagnostics Group Inc (NASDAQ:IDXG) announced that the Company has entered into a Laboratory Services Agreement with Einstein Medical Center of Philadelphia (Einstein) …
Interpace Diagnostics Group Inc (NASDAQ:IDXG) shares rose nearly 8% in after-hours trading Wednesday, after the company announced that it is launching a new biomarker …
Interpace Diagnostics Group Inc (NASDAQ:IDXG) announced financial results and business progress for the quarter ended March 31, 2017, as well as recent accomplishments. “Continued …
Interpace Diagnostics Group Inc (NASDAQ:IDXG) announced the data presented in six posters at this week’s Digestive Disease Week (DDW) meeting held May 6th-9th …
